Published in Mol Pharmacol on May 01, 1992
High-throughput evaluation of relative cell permeability between peptoids and peptides. Bioorg Med Chem (2008) 1.09
Assessing Physicochemical Properties of Drug Molecules via Microsolvation Measurements with Differential Mobility Spectrometry. ACS Cent Sci (2017) 0.85
Weak binding of VX-478 to human plasma proteins and implications for anti-human immunodeficiency virus therapy. J Infect Dis (1995) 2.42
Mechanism of action of 1-beta-D-2,6-diaminopurine dioxolane, a prodrug of the human immunodeficiency virus type 1 inhibitor 1-beta-D-dioxolane guanosine. Antimicrob Agents Chemother (2001) 1.17
Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model. Antimicrob Agents Chemother (1994) 1.08
Structural and functional characterization of the HPV16 E7 protein expressed in bacteria. J Biol Chem (1993) 0.99
Crosslinking of substrates occurs exclusively to the p66 subunit of heterodimeric HIV-1 reverse transcriptase. Biochem Biophys Res Commun (1991) 0.98
DNA polymerase activity of hepatitis B virus particles: differential inhibition by L-enantiomers of nucleotide analogs. Antiviral Res (1996) 0.94
Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virus. Antimicrob Agents Chemother (1993) 0.92
Conformational changes induced in herpes simplex virus DNA polymerase upon DNA binding. Proc Natl Acad Sci U S A (1993) 0.88
Dynamic aspects of ionophore mediated membrane transport. Top Curr Chem (1982) 0.85
Identification of the nucleotide binding site of HIV-1 reverse transcriptase using dTTP as a photoaffinity label. Biochemistry (1993) 0.83
Recombinant human immunodeficiency virus type 1 reverse transcriptase is heterogeneous. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.81
An analysis of the catalytic cycle of HIV-1 reverse transcriptase: opportunities for chemotherapeutic intervention based on enzyme inhibition. Curr Pharm Des (2000) 0.80
Equilibrium cation binding selectivity of the carboxylic ionophore narasin A: a comparison with transport selectivities reported in two biological test systems. Biochem Pharmacol (1986) 0.79
Investigation of the stereochemical course of DNA synthesis catalysed by human immunodeficiency virus type 1 reverse transcriptase. Biochem Biophys Res Commun (1989) 0.78
Safety assessment, in vitro and in vivo, and pharmacokinetics of emivirine, a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1. Antimicrob Agents Chemother (2000) 0.78
Conformational dynamics of the carboxylic ionophore lasalocid A underlying cation complexation-decomplexation and membrane transport. Biochemistry (1982) 0.76
The role of molecular conformation in ion capture by carboxylic ionophores: a circular dichroism study of narasin A in single-phase solvents and liposomes. Biochim Biophys Acta (1986) 0.76
Carrier-independent entry of 1-methyl-4-phenylpyridinium (MPP+) into adrenal chromaffin cells as a consequence of charge delocalization. Biochem Biophys Res Commun (1990) 0.75
Accumulation of 1-methyl-4-phenylpyridinium (MPP+) into bovine chromaffin granules results in a large restriction of its molecular motion: a 13C and 31P NMR study. Biochem Biophys Res Commun (1988) 0.75
The effects of lipid composition on the binding of lasalocid A to small unilamellar vesicles. Biochim Biophys Acta (1990) 0.75